The World of Health & Medicine News

Your daily orange juice could be helping your heart

Your daily orange juice could be helping your heart

Most of us think of orange juice as a simple breakfast habit, something you pour without much thought. Yet scientists are discovering that this everyday drink may be doing far more in the body than quenching thirst.

A recent study has shown that regular orange juice consumption can influence the activity of thousands of genes inside our immune cells. Many of these genes help control blood pressure, calm inflammation and manage the way the body processes sugar, all of which play an important role in long-term heart health.

The study followed adults who drank 500ml of pure pasteurized orange juice every day for two months. After 60 days, many genes associated with inflammation and higher blood pressure had become less active.

These included NAMPT, IL6, IL1B and NLRP3, which usually switch on when the body is under stress. Another gene known as SGK1, which affects the kidneys’ ability to hold onto sodium (salt), also became less active.

Such changes match previous findings that daily orange juice drinking can reduce blood pressure in young adults.

This is noteworthy because it offers a possible explanation for why orange juice has been linked to better heart health in several trials. The new work shows that the drink does not simply raise blood sugar. Instead, it appears to trigger small shifts in the body’s regulatory systems that reduce inflammation and help blood vessels relax.

Natural compounds in oranges, particularly hesperidin, a citrus flavonoid known for its antioxidant and anti-inflammatory effects, seem to influence processes related to high blood pressure, cholesterol balance and the way the body handles sugar.

The response also varies by body size. People carrying more weight tended to show greater changes in genes involved in fat metabolism, while leaner volunteers showed stronger effects on inflammation.

 

spot_img

Explore more

spot_img

Global leaders commit $1.9 billion to eradicate polio amid funding cuts

Global leaders commit $1.9 billion to eradicate polio amid funding cuts Global leaders pledged $1.9 billion to advance polio eradication on Monday, accelerating efforts to...

US FDA qualifies first AI tool to help speed liver disease...

US FDA qualifies first AI tool to help speed liver disease drug development The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed...

Vertex’s gene therapy shows promise in younger children with blood disorders

Vertex's gene therapy shows promise in younger children with blood disorders Vertex Pharmaceuticals (VRTX.O), opens new tab said on Saturday its gene therapy helped children aged between...

Regeneron’s experimental therapy combo effective in untreated cancer patients

Regeneron's experimental therapy combo effective in untreated cancer patients  Regeneron said on Saturday its experimental cancer combination therapy was effective and showed disappearance of the...

BMS scores 5th indication for Breyanzi with FDA marginal zone lymphoma...

BMS scores 5th indication for Breyanzi with FDA marginal zone lymphoma nod With FDA approval to treat marginal zone lymphoma (MZL), Bristol Myers Squibb’s Breyanzi...

World Bank to partner with global vaccine group Gavi on $2...

World Bank to partner with global vaccine group Gavi on $2 billion in funding  The World bank Group ​said on Saturday it ‌was working with the...

Health Rounds: Experimental drug shows promise for stroke patients who miss...

Health Rounds: Experimental drug shows promise for stroke patients who miss the  current medical treatment window Stroke patients who can't get to the hospital quickly...

FDA scrutiny of WHOOP signals challenges for niche wearable device makers

FDA scrutiny of WHOOP signals challenges for niche wearable device makers Niche fitness-tracking firms such as WHOOP are coming under increased regulatory scrutiny as technological...